Intel (INTC) Jun 2026 Filing Analysis

The commercial CHIPS Act agreement was materially amended. Intel received $5.7 billion of accelerated remaining disbursements, while prior project milestones and substantially all other agreement requirements were removed. The filing also reports $1.0 billion of CHIPS Act grants recognized year-to-date, but the original grant-based structure was replaced in part by equity issuance. (1 revised, 1 in progress across 2 tracked commitments)

Management plans to continue investing in process technology and product roadmaps, worldwide manufacturing and assembly/test operations, and future manufacturing expansion. (+2 more commitments)

Management expects R&D and MG&A expenses to decline in 2026 versus recent historical periods as a result of restructuring, cost-reduction measures, and the Altera deconsolidation. — target: Total R&D and MG&A expenses to decrease in 2026 relative to recent historical periods

Management expects industry-wide shortages of substrates, memory, and other critical components to continue into 2027, potentially limiting fulfillment of customer demand, and plans to add factory capacity and secure component supply through long-term supplier agreements. (+1 more commitment)

DCAI expanded its revenue share and operating profitability year over year. Revenue increased 3.5% in the first nine months and rose from 30.3% to 31.1% of consolidated revenue. Server volume increased 10%, although average selling prices fell 6% because of pricing actions and a greater mix of lower-core-count products. The latest quarter was roughly flat, so the expansion is primarily year-to-date rather than an accelerating Q3 trend. (4 expanding across 1 engine)

Foundry profitability improved substantially, but the business remained structurally unprofitable. The Q3 operating loss narrowed 60.0% year over year and the loss margin improved from negative 134% to negative 55%; year-to-date, the loss margin improved from negative 85% to negative 59%. The improvement mainly reflects the absence of $3.1B of prior-year asset impairment and accelerated-depreciation charges, plus lower payroll costs, not established external-customer economics. (2 expanding across 1 engine)

Government support expanded in the latest quarter through a $5.7B accelerated CHIPS Act disbursement, but its nature shifted from future grant funding toward a transaction involving common stock, escrowed shares, and warrants issued to the U.S. Department of Commerce. This strengthens near-term funding for domestic manufacturing while increasing dilution, governance, and regulatory-accounting risk. (1 shifted, 2 expanding, 1 contracting)

The nature of Intel Foundry shifted from primarily an internal manufacturing function toward a potential external customer business. Intel 18A entered high-volume production and was positioned as a node for government and enterprise customers, while Intel 14A was designed from inception for external customers. However, Intel stated that it may pause or discontinue Intel 14A and later nodes if it cannot secure a significant external customer. (2 shifted, 2 expanding)

Intel Foundry's reported revenue increased slightly, but the business remained overwhelmingly internal rather than an external foundry. External revenue increased from $159 million to $307 million, yet represented only about 0.6% of consolidated revenue in FY2025. The segment remained deeply loss-making because of manufacturing investment, depreciation, and early Intel 18A ramp costs. (2 expanding, 1 contracting, 2 shifted)

Intel's US capacity buildout remains an active, multi-quarter expansion program. In Q1 2024, Intel reported $5.97 billion of property, plant, and equipment additions, $592 million of capital-related government incentives, a newly opened Fab 9 in New Mexico, and proposed US CHIPS Act support of up to $8.5 billion in direct funding plus up to $11.0 billion in loans. Later extracted information identifies $13.8 billion of Arizona manufacturing assets placed in service and a long-term Ohio facility. The direction is accelerating in terms of facilities, funding support, and assets entering service, although the filing does not provide a total wafer-capacity target. (4 accelerating, 1 decelerating across 5 signals, 1 leading indicator)

DCAI revenue grew 8% year over year to $4.126 billion in Q1 2025, accelerating from roughly 0% growth in Q1 2024 implied by the prior-year comparison, but the filing provides only one comparable quarter of current-period data. Growth was driven by higher edge-processing demand and hyperscaler-related server demand; server volume rose 16% while server average selling prices fell 10%. (3 accelerating, 1 reversing, 1 decelerating across 5 signals)

Intel launched Intel Foundry and expanded its process roadmap in Q1 2024, including Intel 3, Intel 18A, and Intel 14A. The filing provides no quarterly production or customer-revenue data for these nodes, so this is a newly disclosed pipeline signal rather than a measurable revenue trend. Later extracted information shows 18A reaching high-volume production in early 2026 and 18A-P entering risk production in June 2026, confirming progression from roadmap announcement to manufacturing ramp. (5 new trend across 5 signals, 1 leading indicator)

External foundry revenue was only $27 million in Q1 2024, down from $118 million in Q1 2023, a 77% decline in the consolidated external-foundry revenue disclosure. The later extracted Q2 2026 figure of $293 million, up from $22 million a year earlier, shows a subsequent recovery and new customer traction. Across the available periods, the latest data indicate a reversal from early contraction to accelerating external foundry growth, but the business remains small relative to Intel's internal foundry activity. (3 accelerating, 2 reversing across 5 signals, 1 leading indicator)

Gross margin improved sharply because the prior-year period included large manufacturing-asset impairment and accelerated-depreciation charges, not because of comparable revenue acceleration. Consolidated gross margin rose from 15.0% to 38.2% in Q3 and from 30.3% to 34.3% year to date, while R&D plus marketing and administrative expense fell from 40.9% to 31.9% of revenue in Q3 and from 43.6% to 35.7% year to date. (2 accelerating, 3 reversing across 5 signals)

Mobileye's competitive position and execution are deteriorating enough to threaten additional write-downs. The company cited stronger competition, uncertainty around advanced autonomous-driving technology, and a higher valuation discount rate. [COMPETITIVE]

The risk was very high in Q3 FY25. Foundry reported a $2.321 billion quarterly operating loss on $4.235 billion of revenue, or a negative 55% margin; year-to-date margin was negative 59%. Intel also reported higher period charges, excess capacity, and $797 million of manufacturing-asset impairment and accelerated depreciation in FY25. The Jun. 2026 baseline reported that higher-cost Intel 18A wafers were offsetting revenue and cost improvements, with product profit down year over year. Thus, the underlying margin-recovery risk intensified from HIGH in the older Q3 FY25 period to HIGH in the later baseline. (4 intensifying, 1 high-severity)

INTENSIFYING. FY2025 included concrete supply shortfalls: CCG and DCAI demand exceeded available internal wafer supply in Q4, particularly for Intel 7 and Intel 3, and management expected the constraints to persist into 2026, with the worst impact in Q1. The filing also identified industry-wide shortages of substrates, memory, foundry capacity, and reliance on sole-source EUV tools from ASML. The Jun 2026 baseline continued to identify shortages of substrates, memory, helium, and other inputs, indicating that the constraint risk broadened rather than resolved. (3 intensifying, 1 high-severity)

INTENSIFYING. In the older FY2025 filing, Intel Foundry remained deeply loss-making: a $10.318 billion operating loss on $17.826 billion of revenue, or a negative 58% operating margin. External foundry revenue was only $307 million, while $17.5 billion was intersegment revenue, showing that the business was still overwhelmingly dependent on internal Intel demand. By the Jun 2026 baseline, the loss had narrowed to $2.089 billion in Q2 2026, but the company was still loss-making while committing to Intel 14A expansion. The absolute loss improved, but the strategic risk became more concentrated around whether future external demand can support the investment. (4 intensifying, 1 easing, 2 high-severity)

In Q3 FY25, DCAI revenue was essentially flat year over year at $4.117 billion versus $4.141 billion, although year-to-date revenue rose 3% because of higher hyperscale demand. Server volume increased 10%, but server average selling price fell 6%, mainly because of competitive pricing and a greater mix of lower-core-count products. This showed both customer concentration and margin sensitivity. By Jun. 2026, the baseline described materially stronger but more concentrated hyperscaler-driven growth, with DCAI revenue up 59% and server pricing up 48%. The larger dependence on a small number of cloud customers increased the downside if their spending or product mix changes. Severity rose from MEDIUM to HIGH. (4 intensifying, 1 easing, 2 high-severity)